Liver Cancer Clinical Trials

A listing of Liver Cancer medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 732 clinical trials
None
Huaier Granule for Prevention of Recurrence and Metastasis of Hepatocarcinoma Following Local Ablation

To evaluate the efficacy and safety of Huaier Granule for Prevention of Recurrence and Metastasis of Hepatocarcinoma following Local Ablation

platelet count
cancer
liver disease
prothrombin
ct scan
  • 56 views
  • 25 Jul, 2021
  • 17 locations
None
Pembrolizumab in Hepatocellular Carcinoma

This is a single-arm Phase II trial of pembrolizumab in patients with hepatitis B virus-related hepatocellular carcinoma with parallel study on baseline and serial change in the immune environment. Subjects should have a confirmed diagnosis of HCC (in accordance with the AASLD guideline) and confirmed chronic infection with hepatitis B …

measurable disease
hepatitis b surface antigen
antiviral therapy
hepatitis
prothrombin
  • 1 views
  • 24 Oct, 2021
  • 1 location
None
Hepatocellular Carcinoma on Cirrhosis With Child A/B7 and Hepatic Intra Arterial Injection of Idarubicin/Lipiodol Emulsion

The investigators propose in this trial to test a hepatic chemotherapy, consisting of the hepatic intra-arterial injection Idarubicin, emulsified with Lipiodol, lipid vector, without embolization in the treatment of non-metastatic, unresectable hepatocellular carcinoma on cirrhosis with Child-Pugh A/B7.

cirrhosis
unresectable hepatocellular carcinoma
radioembolization
neutrophil count
arterial embolization
  • 7 views
  • 23 Jan, 2021
  • 3 locations
None
Microwave Ablation Versus Liver Resection For Early Hepatocellular Carcinoma in Patients With Borderline Liver Function

We propose a randomized controlled study to compare the treatment efficacy of microwave ablation to liver resection for hepatocellular carcinoma (HCC) in patients with borderline liver function.

metastasis
hepatectomy
  • 0 views
  • 11 Aug, 2021
  • 1 location
None
Sequential TransArterial Chemoembolization and Stereotactic RadioTherapy With ImmunoTherapy for Downstaging Hepatocellular Carcinoma for Hepatectomy

This study is a prospective phase II, single arm mono-institutional study conducted in Queen Mary Hospital (Hong Kong) assessing the efficacy and safety of the sequential administration of trans-arterial chemo-embolization (TACE) and stereotactic body radiotherapy (SBRT) with an immune checkpoint inhibitor in hepatocellular carcinoma (HCC) patients.

chemoembolization
platelet count
stereotactic body radiation therapy
measurable disease
liver disease
  • 0 views
  • 23 Jan, 2021
  • 1 location
None
Sorafenib Combined With Arsenical in Treating Patients With Recurrent HCC After Liver Transplantation

To analyze the safety, efficacy and pharmacokinetic characteristics of sorafenib combined with compound huangdai tablets in patients with recurrent hepatocellular carcinoma after liver transplantation

liver transplant
platelet count
cancer
antiviral therapy
sorafenib
  • 1 views
  • 23 Jan, 2021
  • 1 location
None
Genetic Polymorphisms of TNF- Promoter and HBV Genotype on Outcome of HBV-Related Chronic Liver Disease

The prognosis of Hepatitis B virus (HBV)infection varies from minimal progressive liver disease to cirrhosis or hepatocellular carcinoma (HCC).Both viral and host genetic factors contribute to disease severity. Cytokine gene polymorphism has been regarded affecting prognosis of disease. By detecting HBV genotyping and tumor necrosis factor-alpha polymorphism, this study aime …

cirrhosis
tumor necrosis factor
liver disease
hepatitis
carcinoma
  • 0 views
  • 07 Nov, 2020
  • 1 location
None
Phase Study of Tyroserleutide for Injection in Hepatocellular Carcinoma(HCC) Patients

The investigation is a randomized, double-blind, placebo involved and multi-center clinical trial. All subjects are assigned to 4 groups, including 3mg, 6mg, 12mg per day and placebo group. Each group includes 25 subjects, who have hepatic-cellular carcinoma accompanied with branch vein thrombosis. They receive investigational drug 40 days after resection …

thrombosis
fluorouracil
  • 1 views
  • 07 Nov, 2020
  • 1 location
None
Evaluation of Quality of Life and Survival With MS-20 in Patient With Advanced Hepatocellular Carcinoma (FDA IND 74572)

To evaluate Quality of Life (QoL) score of MS-20 versus placebo in advanced HCC patients using European Organization for Research and Treatment of Cancer (EORTC) QLQ C-30 questionnaire.

cirrhosis
hepatoma
cancer
systemic chemotherapy
ct scan
  • 1 views
  • 07 Nov, 2020
  • 1 location
None
Trial of Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma

The purpose of this study is to compare the efficacy and safety of cisplatin (CDDP) and epirubicin (EPI) in the treatment of transcatheter chemoembolization for Hepatocellular Carcinoma (HCC).

transcatheter arterial chemoembolisation
chemoembolization
hepatoma
TACE
  • 4 views
  • 07 Nov, 2020
  • 1 location